San Bruno, CA, United States of America

Jianlong Lou

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 75(Granted Patents)


Location History:

  • San Bruno, CA (US) (2010 - 2021)
  • San Francisco, CA (US) (2021 - 2023)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations by Jianlong Lou: Pioneering Antibody Research

Introduction

Jianlong Lou is a distinguished inventor based in San Bruno, California, with an impressive portfolio of 14 patents. His work primarily focuses on the development of innovative antibodies that address important medical challenges, particularly in the field of immunotherapy.

Latest Patents

Lou’s recent contributions to the field include groundbreaking patents such as "Antibodies that bind integrin αvβ8 and uses thereof," which details antibodies that specifically target the αvβ8 integrin. Another significant patent is "Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy," which describes novel antibodies and methods that enhance immunotherapeutic strategies.

Career Highlights

Jianlong Lou is associated with the University of California, where he leverages his expertise to advance research and development in antibody technology. His career is marked by significant contributions that have the potential to revolutionize treatments for various conditions through targeted therapies.

Collaborations

Throughout his career, Lou has collaborated with notable colleagues including James David Marks and Stephen L. Nishimura. These partnerships have facilitated the exchange of ideas and the advancement of innovative research in the field of antibodies and immunotherapy.

Conclusion

As an inventor, Jianlong Lou exemplifies the spirit of innovation with his array of patents that seek to push the boundaries of medical science. His work has not only enhanced our understanding of integrin interactions but also holds promise for improved therapeutic approaches in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…